Business Name: |
Innofect |
Contact Person: |
Paul Axelsen |
Address: |
3160 Chestnut St, Philadelphia, Pennsylvania 19104 |
Phone Number: |
(215) 573-8196 |
Annual Revenue (USD): |
$50.000 to $99.999 |
Founding Year: |
2009 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2B (Business to Business) |
Business Category: |
Research and Development Laboratories |
SIC Code: |
8731 |
NAICS Code: |
541712 |
Share This Business: |
|
Related Businesses: |
Fibradigm Therapeutics LLC - Philadelphia, PA 19104 Axonia Medical LLC - Philadelphia, PA 19104 Micropathid D Iagnostics LLC - Philadelphia, PA 19104 Myostratum LLC - Philadelphia, PA 19104 Neuronai LLC - Philadelphia, PA 19104 Invidisyn LLC - Philadelphia, PA 19104 Oxygense - Philadelphia, PA 19104 Relgene LLC - Philadelphia, PA 19104 Mem Technologies LLC - Philadelphia, PA 19104 Cellulosic Biotherapeutics LLC - Philadelphia, PA 19104 Translatum LLC - Philadelphia, PA 19104 Biosucran - Philadelphia, PA 19104 Cognizance Biomarkers LLC - Philadelphia, PA 19104 Wilson Robert D MD - Philadelphia, PA 19104 Graphene Frontiers LLC - Philadelphia, PA 19104 Anosos Biotherapeutics LLC - Philadelphia, PA 19104 Sunstone Biosciences Inc - Philadelphia, PA 19104 Quern Therapeutics - Philadelphia, PA 19104 Mitergy LLC - Philadelphia, PA 19104 Sante Biosciences - Philadelphia, PA 19104 |
The company Innofect provides B2B services in the form of Research and Development Laboratories from its single location in Pennsylvania.
1 to 4 employees work for Innofect, and the business now earns $50.000 to $99.999 per annum.
Innofect was launched in 2009 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 .
To contact Innofect, please call Paul Axelsen with the phone number (215) 573-8196 or visit its single location at 3160 Chestnut St in Philadelphia, Pennsylvania 19104.
The location of the single location can also be found using the coordinates 39.953553,-75.18659.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.